Welcome to Curachem
 
 
 
 
 
 
News
 
 
 
  News  
 
 

December, 2016 Curachem debuts a dedicated 14C GMP API manufacturing facility

Curachem has increased its manufacturing capacity significantly within the last year after its move to a purpose-built facility near Seoul, Korea.  The multi-level facility houses over 70 operating fume hoods, along with a dedicated 3-suite 14C GMP API (Active Pharmaceutical Ingredient) space isolated from non-GMP manufacture areas. The GMP manufacturing capabilities were specifically implemented to support human radiotracer studies (mass balance and metabolism studies) or for any study where GMP level quality assurance is critical. Curachem can now satisfy all of our customer's demands for non-GMP and GMP suitable 14C-API for preclinical and clinical investigations.  

LIST